Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography

Jong Woo Kim1, Hyun Woo Goo

  • 1Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Insights

CT coronary angiography (CTCA) offers superior diagnostic performance compared to MR coronary angiography (MRCA) for evaluating coronary artery abnormalities in Kawasaki disease patients. Both methods show similar patient-level assessibility, but CTCA is more accurate.

Area of Science:

  • Cardiovascular Imaging
  • Pediatric Cardiology
  • Medical Diagnostics

Background:

  • Kawasaki disease frequently leads to coronary artery abnormalities, necessitating accurate imaging surveillance.
  • CT coronary angiography (CTCA) and MR coronary angiography (MRCA) are utilized, but direct comparisons are limited.
  • Assessing the relative strengths of CTCA and MRCA in this specific patient population is crucial for optimal management.

Purpose of the Study:

  • To directly compare the diagnostic performance and assessibility of CTCA versus MRCA.
  • To determine the preferred imaging modality for evaluating coronary artery abnormalities in pediatric Kawasaki disease patients.

Main Methods:

  • A cohort of 56 Kawasaki disease patients (aged 1-24 years) underwent either CTCA or MRCA.
  • A subset of 17 patients had both CTCA and MRCA performed for direct comparison.
  • Coronary artery segments were assessed for visibility, aneurysm, stenosis, and occlusion, with results validated against a reference standard.

Main Results:

  • CTCA demonstrated significantly higher diagnostic performance (sensitivity, accuracy) than MRCA across both patient groups.
  • While per-segment assessibility favored CTCA, per-patient assessibility was comparable between the two modalities.
  • CTCA showed superior sensitivity (93.1% vs. 77.9%) and accuracy (98.0% vs. 94.9%) in group A.

Conclusions:

  • CTCA exhibits superior diagnostic performance for detecting coronary artery abnormalities in Kawasaki disease compared to MRCA.
  • Despite comparable patient-level assessibility, CTCA is the preferred modality due to its higher accuracy.
  • These findings support the use of CTCA for comprehensive evaluation of coronary artery sequelae in Kawasaki disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...